Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Winningham Rick E
Relationship:  
City:   South San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   2,688,476    

Indirect Shares

   96,467      
Direct Value   $31,541,999    

Indirect Value

   $896,178      
Total Shares   2,784,943      
Total Value   $32,438,177      


Innoviva Inc $13,189,748 Jazz Pharmaceuticals Inc $1,141,216 Theravance Biopharma, Inc. $17,211,035 Innoviva Inc $13,189,748 Jazz Pharmaceuticals Inc $1,141,216 Theravance Biopharma, Inc. $17,211,035
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
     0.0%
 -15.1%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Innoviva Inc INVA Director 2014-08-15 825,391 2008-01-29 0    Premium*  
            Jazz Pharmaceuticals Inc JAZZ Director 2023-08-14 10,444 2012-01-11 0    Premium*  
            Theravance Biopharma, Inc. TBPH 2024-05-15 1,852,641 2024-05-15 96,467    Premium*  
* Premium Members only  

Records found :    131         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
INVA Innoviva Inc Chief Executive Officer   •       •      –    2012-05-20 4 D $20.33 $217,145 D/D (10,681) 521,846 0 -
INVA Innoviva Inc Chief Executive Officer   •       •      –    2012-08-20 4 D $27.01 $288,494 D/D (10,681) 580,577 0 -
TBPH Theravance Biopharma, Inc... CHIEF EXECUTIVE OFFICER   •       •      –    2024-03-15 4 GD $0.00 $0 D/D 10,900 1,550,573 0 -
INVA Innoviva Inc Chief Executive Officer   •       •      –    2012-02-15 4 A $0.00 $0 D/D 11,000 490,688 0 -
INVA Innoviva Inc Chief Executive Officer   •       •      –    2012-10-15 4 A $0.00 $0 D/D 11,000 591,577 0 -
INVA Innoviva Inc Chief Executive Officer   •       •      –    2013-02-07 4 A $0.00 $0 D/D 11,000 602,577 0 -
INVA Innoviva Inc Chief Executive Officer   •       •      –    2013-07-24 4 A $0.00 $0 D/D 11,000 722,505 0 -
TBPH Theravance Biopharma, Inc... CHIEF EXECUTIVE OFFICER   •       •      –    2022-05-20 4 D $8.74 $96,359 D/D (11,025) 1,440,588 0 -
TBPH Theravance Biopharma, Inc... Chief Executive Officer   •       •      –    2021-05-20 4 D $17.80 $202,991 D/D (11,404) 1,324,818 0 -
TBPH Theravance Biopharma, Inc... Chief Executive Officer   •       •      –    2021-08-20 4 D $14.05 $160,226 D/D (11,404) 1,313,414 0 -
TBPH Theravance Biopharma, Inc... Chief Executive Officer   •       •      –    2018-02-20 4 D $29.09 $378,315 D/D (13,005) 881,372 0 -
TBPH Theravance Biopharma, Inc... Chief Executive Officer   •       •      –    2019-02-20 4 D $27.00 $363,879 D/D (13,477) 1,099,462 0 -
TBPH Theravance Biopharma, Inc... Chief Executive Officer   •       •      –    2020-05-20 4 D $26.67 $371,940 D/D (13,946) 1,303,061 0 -
TBPH Theravance Biopharma, Inc... Chief Executive Officer   •       •      –    2020-08-20 4 D $18.22 $254,096 D/D (13,946) 1,289,115 0 -
TBPH Theravance Biopharma, Inc... Chief Executive Officer   •       •      –    2020-11-20 4 D $17.21 $240,011 D/D (13,946) 1,275,169 0 -
TBPH Theravance Biopharma, Inc... Chief Executive Officer   •       •      –    2017-05-20 4 D $36.83 $569,392 D/D (15,460) 856,377 0 -
TBPH Theravance Biopharma, Inc... Chief Executive Officer   •       •      –    2018-08-20 4 D $26.95 $419,261 D/D (15,557) 904,063 0 -
TBPH Theravance Biopharma, Inc... Chief Executive Officer   •       •      –    2018-11-20 4 D $24.79 $385,658 D/D (15,557) 795,939 0 -
TBPH Theravance Biopharma, Inc... CHIEF EXECUTIVE OFFICER   •       •      –    2022-08-19 4 D $9.34 $147,609 D/D (15,804) 1,424,784 0 -
TBPH Theravance Biopharma, Inc... CHIEF EXECUTIVE OFFICER   •       •      –    2022-11-20 4 D $10.85 $171,473 D/D (15,804) 1,409,797 0 -
TBPH Theravance Biopharma, Inc... CHIEF EXECUTIVE OFFICER   •       •      –    2023-05-20 4 D $11.21 $177,163 D/D (15,804) 1,627,573 0 -
TBPH Theravance Biopharma, Inc... CHIEF EXECUTIVE OFFICER   •       •      –    2023-08-20 4 D $9.70 $153,299 D/D (15,804) 1,611,769 0 -
TBPH Theravance Biopharma, Inc... CHIEF EXECUTIVE OFFICER   •       •      –    2023-11-20 4 D $10.37 $163,887 D/D (15,804) 1,595,965 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2018-08-09 4 S $176.03 $2,814,838 D/D (15,979) 5,610 0 -
TBPH Theravance Biopharma, Inc... Chief Executive Officer   •       •      –    2015-08-17 4 B $12.13 $204,512 D/D 16,860 602,056 2.81 -
  131  Records found
  1   2   3  4   5   6      
  Page 3 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us